Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients

• Xiaorong Zhong ,

  Contributed equally to this work with: Xiaorong Zhong, Zhengwei Dong, Hua Dong

  Affiliation Laboratory of Molecular Diagnosis of Cancer, State Key Laboratory of Biotherapy, National Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu Sichuan, P. R. China

  ⨯
• Zhengwei Dong ,

  Contributed equally to this work with: Xiaorong Zhong, Zhengwei Dong, Hua Dong

  Affiliation Asia and Emerging Markets iMed, AstraZeneca, Shanghai, P. R. China

  ⨯
• Hua Dong ,

  Contributed equally to this work with: Xiaorong Zhong, Zhengwei Dong, Hua Dong

  Affiliation Asia and Emerging Markets iMed, AstraZeneca, Shanghai, P. R. China

  ⨯
• Jiayuan Li,

  Affiliation Department of Epidemiology and Bio-Statistics, West China School of Public Health, Sichuan University, Chengdu, Sichuan, P.R. China

  ⨯
• Zuxiang Peng,

  Affiliations Laboratory of Molecular Diagnosis of Cancer, State Key Laboratory of Biotherapy, National Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu Sichuan, P. R. China, Department of Thyroid and Breast Surgery, West China Hospital, Sichuan University, Chengdu Sichuan, P. R. China

  ⨯
• Ling Deng,

  Affiliation Laboratory of Molecular Diagnosis of Cancer, State Key Laboratory of Biotherapy, National Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu Sichuan, P. R. China

  ⨯
• Xuehua Zhu,

  Affiliation Asia and Emerging Markets iMed, AstraZeneca, Shanghai, P. R. China

  ⨯
• Yun Sun,

  Affiliation Asia and Emerging Markets iMed, AstraZeneca, Shanghai, P. R. China

  ⨯
• Xuesong Lu,

  Affiliation Asia and Emerging Markets iMed, AstraZeneca, Shanghai, P. R. China

  ⨯
• Fuxiao Shen,

  Affiliation Asia and Emerging Markets iMed, AstraZeneca, Shanghai, P. R. China

  ⨯
• Xinying Su,

  Affiliation Asia and Emerging Markets iMed, AstraZeneca, Shanghai, P. R. China

  ⨯
• Liying Zhang,

  Affiliation Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America

  ⨯
• Yi Gu ,

  * E-mail: yigu68@yahoo.com (YG); hzheng@scu.edu.cn (HZ)

  Affiliation Asia and Emerging Markets iMed, AstraZeneca, Shanghai, P. R. China

  ⨯
• Hong Zheng

  * E-mail: yigu68@yahoo.com (YG); hzheng@scu.edu.cn (HZ)

  Affiliations Laboratory of Molecular Diagnosis of Cancer, State Key Laboratory of Biotherapy, National Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu Sichuan, P. R. China, Cancer center, West China Hospital, Sichuan University, Chengdu, Sichuan, P. R. China

  ⨯